The aim of this study was to investigate whether the serum levels of IL-16 and IL-16 mRNA (messenger RNA) skin expression correlate with clinical severity of psoriasis and mRNA skin expression for CD4. Moreover, genotype and allele frequencies for -295 T/C IL-16 promoter gene polymorphism were analyzed. This evidence concerns the gene CD4 and psoriasis.